Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
MedTech
Abbott to replace CGMs after incorrect readings, death reports
A manufacturing defect on a single production line may have affected about 3 million FreeStyle Libre 3 and Libre 3 Plus sensors in the U.S.
Conor Hale
Nov 24, 2025 12:11pm
Startups at AHA tout innovative tech for heart, brain health
Nov 17, 2025 4:15pm
Dexcom hit by FDA Class I recall for its CGM system app
Nov 5, 2025 8:45am
Novo ends all cell therapy R&D, lets go of staff
Oct 10, 2025 3:30pm
Barinthus enters reverse merger with metabolic disease biotech
Sep 30, 2025 10:39am
Sparrow flits forward with $95M for midstage diabetes asset
Sep 24, 2025 11:22am
